Navigation Links
Bionomics Achieves US$1 Million Milestone Payment from Genmab
Date:2/19/2008

ADELAIDE and COPENHAGEN, Feb. 19 /PRNewswire-FirstCall/ -- Bionomics Limited (ASX: BNO, US OTC: BMICY) today announced the successful completion of pre-clinical testing on the first of eight proteins licensed to US $2.6 billion Danish antibody company Genmab A/S (OMX: GEN), triggering a US $1 million milestone payment.

Under the agreement, which was executed in February 2006, Genmab acquired the exclusive worldwide rights to eight proteins identified and characterised by Bionomics using its proprietary Angene(R) angiogenesis platform. Antibodies to these proteins have potential as treatments for cancer and other diseases. At the time of the agreement, Bionomics received an upfront fee and the US $1 million is the first in a series of potential milestone payments upon achieving specified pre-clinical and clinical milestones. Bionomics will also receive milestone payments and royalties on product sales for each product reaching the market.

The US $1 million payment has been triggered with the significant progress made in the first stage of evaluation of the licensed proteins. This evaluation strongly supported the potential of a selection of the licensed proteins as antibody targets and development of a therapy to treat pathological angiogenic conditions. This milestone marks commencement of the next phase of the development program under the collaboration.

"This is a very significant milestone for Bionomics as it validates Bionomics' Angene(R) platform as a source of new treatment modalities for cancer and other conditions involving pathological formation of new blood vessels. It also reinforces for our shareholders the significant commercial potential of our collaboration with Genmab," said CEO of Bionomics Dr. Deborah Rathjen.

"We have been working in close collaboration with Genmab for several years and this latest milestone is a clear validation of the strength of this partnership which aims to bring new antibody-based treatment
'/>"/>

SOURCE Bionomics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
2. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
3. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
4. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
5. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
6. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
7. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
8. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
9. BioVascular Inc. Closes $10.87 Million Series C Financing
10. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
11. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 30, 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... technology platform company serving the pharmaceutical, biotechnology, and medical ... and the United States , ... the Tel Aviv area of ... WuXi,s broad platform of integrated R&D services to local ...
(Date:10/30/2014)... Boston Scientific Corporation (NYSE: BSX ... Suisse Annual Healthcare Conference on Tuesday, November 11, 2014 ... Brennan , executive vice president and chief financial officer, ... approximately 8:00 a.m. PT followed by a question and ... presentation and question and answer session will be available ...
(Date:10/30/2014)... , Oct. 30, 2014   ViaDerma, Inc. ... to bringing new products to market, has recently ... TetraStem. TetraStem is a topical liquid tetracycline-based antibiotic ... that can convert oral medication active ingredients into ... a first aid antibiotic to help prevent skin ...
Breaking Medicine Technology:WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3
... 27, 2011 Pepto-Bismol announced today that for the second ... white and … PINK? In an act of true gastro-patriotism, ... Nathan,s Famous Fourth of July International Hot Dog Eating Contest ... To make this contest a celebration to remember, Pepto-Bismol has ...
... Recent findings published in the scientific journal Leukemia ... with standard anti-leukemia agents, the biological activity of Leukothera ... Biomed, Inc., showed synergistic anti-leukemia effects. ... demonstrated that combining Leukothera TM with ...
Cached Medicine Technology:Pepto-Bismol and Nick Cannon Heat Things up at this Year's Nathan's Famous Fourth of July International Hot Dog Eating Contest 2Pepto-Bismol and Nick Cannon Heat Things up at this Year's Nathan's Famous Fourth of July International Hot Dog Eating Contest 3Recent Study Shows Leukothera™ Combined with Other Agents Has Enhanced Anti-Leukemia Effects 2
(Date:10/31/2014)... (PRWEB) October 31, 2014 The Memory Healer ... created by Alexander Lynch, whose father suffered from Alzheimer's disease. ... dramatic moment, caused by his father's disease. His father pointed ... was the crucial moment when the author of this method ... dad. , The Memory Healer program is based on ...
(Date:10/31/2014)... With all the preparations families carry out ... may overlook one critical area – the potential for ... performance and even behavior. Typical children’s vision screenings at ... vision problems, and to address this challenge, Dr. Rosenak’s ... The Awesome Eyes Student Vision Program. , The ...
(Date:10/31/2014)... -- Obesity increases the risk of certain types of ... new U.S. studies show. One study of more ... increased the risk for estrogen receptor-negative and progesterone receptor-positive ... for a long time for white women, but now ... author Esther John, a senior research scientist at the ...
(Date:10/31/2014)... CA (PRWEB) October 31, 2014 Gold ... shoppers to find affordable but tasteful gifts for the wine ... Annual Early Bird Gift Giving Special , which Early ... when they purchase Wine Club Gift membership. , Gift ... advantage of this special. Besides offering discounts, Gold Medal Wine ...
(Date:10/31/2014)... 2014 Florida Air Academy, the ... in grades 6-12, is taking the lead when ... and concussions, becoming the first high school in ... Post-Concussion Assessment and Cognitive Testing) computerized assessment to ... lawsuit grabs the headlines, and the Centers for ...
Breaking Medicine News(10 mins):Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3
... sickle cell disease who also have lower blood oxygen ... have heart abnormalities, researchers at Washington University School of ... Heart problems are fairly common in young adults ... why. The researchers demonstrated that lower oxygen saturation in ...
... ... (radial Keratotomy) may benifit from PRELEX with crystalens according to Dr. Khanna. , ... (Vocus) April 27, 2010 -- Patents that ... Khanna. Radial Keratotomy was in vogue in the late seventy’s and eighties. Its popularity declined ...
... function , TUESDAY, April 27 (HealthDay News) -- High-dose ... and patients on this regimen should stop immediately, says a ... believed it would show that high-dose vitamin B therapy (folic ... function and reduce their risk of heart attack and stroke. ...
... study finds problems contracting, relaxing, , TUESDAY, April 27 ... the heart more than had been thought, a new ... what might be the first clear evidence that these ... damage heart function, said Dr. Aaron L. Baggish, an ...
... Digestive Health and Nutrition (FDHN) announced this year,s recipient ... Kenneth P. Olive, PhD. The $225,000 gift from ... with funding and protected time for three years to ... Schwartz, a businessman and photographer, suffered from the disease ...
... ... to select their perfect retirement community based on community culture, personality, amenities and personal preferences. ... Princeton, NJ (PRWEB) ... can be a complicated, confusing chore. In fact, retirees and their families must choose ...
Cached Medicine News:Health News:Low blood oxygen may lead to heart defects in children with sickle cell disease 2Health News:Low blood oxygen may lead to heart defects in children with sickle cell disease 3Health News:Crystalens HD May Help People with RK 2Health News:Steroids Could Harm Heart's Pumping Ability 2Health News:Steroids Could Harm Heart's Pumping Ability 3Health News:Second AGA Foundation/Bernard Lee Schwartz Foundation Research Scholar Award presented 2Health News:RetiringbyDesign.com Offers Retirees a Smarter Way to Explore Living Options 2Health News:RetiringbyDesign.com Offers Retirees a Smarter Way to Explore Living Options 3
Lens Plus rewetting drops for soft contact lenses....
Sensitive Eyes drops keep soft contact lenses moist....
... preservative free lubricating and rewetting ... eyes while you're wearing soft ... free formula is ideal for ... to preservatives and for frequent ...
For use to rewet and lubricate lenses during wear. Soothes and moisturizes eyes while wearing soft contact lenses....
Medicine Products: